Recent Updates
Recently added Catalysts
RMTI Positive Sentiment

Rockwell Medical to Release Fourth Quarter and Full-Year 2025 Results on Thursday, March 26, 2026

Key Takeaway: Rockwell Medical, Inc. will announce its financial and operational results for Q4 and the full year of 2025 on March 26, 2026. The announcement will include a press release at 6:00am ET and a live webcast at 8:00am ET. The company emphasizes its commitment to providing high-quality hemodialysis products and exceptional customer service.
Price reaction · baseline $9.301 (2026-02-25 close) · hit pre-market · clean, no other RMTI news in the window
day 0 close
+0.1%

Market Sentiment Analysis

POSITIVE FACTORS

  • Rockwell Medical is set to release its financial results, indicating transparency.
  • The company has been recognized as a Great Place to Work for four consecutive years.
  • Rockwell Medical's focus on innovation suggests potential for growth.

Full Press Release Details

WIXOM, Mich.--(BUSINESS WIRE)--Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that it will release its financial and operational results for the fourth quarter and full-year ended December 31, 2025 on Thursday, March 26, 2026. The Company will issue a press release at 6:00am ET followed by a live webcast at 8:00am ET.
$RMTI to release its Q4/FY'25 financial and operational results on Thursday, March 26, 2026.

WEBCAST DETAILS

Date:Thursday, March 26, 2026

Time:8:00am ET

Webcast and Replay:www.RockwellMed.com/Results

Speakers:

Format:Discussion of fourth quarter and full-year 2025 financial and operational results followed by Q&A.

ABOUT ROCKWELL MEDICAL

Rockwell Medical, Inc. (Nasdaq: RMTI) is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers worldwide. Rockwell Medical's mission is to provide dialysis clinics and the patients they serve with the highest quality products supported by the best customer service in the industry. Rockwell is focused on innovative, long-term growth strategies that enhance its products, its processes, and its people, enabling the Company to deliver exceptional value to the healthcare system and provide a positive impact on the lives of hemodialysis patients. Hemodialysis is the most common form of end-stage kidney disease treatment and is typically performed in freestanding outpatient dialysis centers, hospital-based outpatient centers, skilled nursing facilities, or a patient’s home. Rockwell Medical's products are vital to vulnerable patients with end-stage kidney disease, and the Company is relentless in providing unmatched reliability and customer service. Certified as a Great Place to Work®four years in a row (2023-2026) and named Fortune Best Workplaces in Manufacturing & Production™ in 2024 and 2025, Rockwell Medical isDriven to Deliver Life-Sustaining Dialysis Solutions™. For more information, visitwww.rockwellmed.com.

Frequently Asked Questions

When will Rockwell Medical release its Q4 and FY 2025 results?

Rockwell Medical will release its Q4 and FY 2025 results on March 26, 2026.

What time is the webcast for Rockwell Medical's results?

The webcast for Rockwell Medical's results is scheduled for 8:00am ET.

How can I access the webcast for Rockwell Medical's results?

The webcast can be accessed at www.RockwellMed.com/Results.

What does Rockwell Medical specialize in?

Rockwell Medical specializes in developing and distributing hemodialysis products.

Last updated: Feb 26, 2026